Sammamish, WA, United States of America

Barbara A Thorne

USPTO Granted Patents = 9 


 

Average Co-Inventor Count = 5.2

ph-index = 7

Forward Citations = 298(Granted Patents)


Location History:

  • Issaquah, WA (US) (2000 - 2002)
  • Sammamish, WA (US) (2005 - 2023)

Company Filing History:


Years Active: 2000-2023

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Barbara A Thorne: Innovator in Gene Therapy

Introduction

Barbara A Thorne is a prominent inventor based in Sammamish, WA (US). She has made significant contributions to the field of gene therapy, holding a total of 9 patents. Her work focuses on the purification of recombinant adeno-associated virus (rAAV) vectors, which are crucial for gene transfer applications.

Latest Patents

Among her latest patents are methods for the purification of recombinant AAV vectors. These methods are designed to ensure that the rAAV vectors used for gene therapy or vaccination are substantially free of in-process impurities. This includes the removal of production components such as cellular nucleic acids, cellular proteins, helper viruses, and media components. The innovation in her patents enhances the safety and efficacy of gene therapy treatments.

Career Highlights

Barbara has worked with notable companies in the pharmaceutical and biotechnology sectors, including Bristol-Myers Squibb Company and Genzyme Corporation. Her experience in these organizations has allowed her to develop and refine her expertise in gene therapy and vector purification.

Collaborations

Throughout her career, Barbara has collaborated with esteemed colleagues such as Diane Hollenbaugh and Alejandro A Aruffo. These partnerships have contributed to her innovative work and advancements in the field.

Conclusion

Barbara A Thorne's contributions to gene therapy through her patents and collaborations highlight her role as a leading inventor in the biotechnology industry. Her work continues to pave the way for advancements in gene transfer technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…